CHEMINFORMATICS.ORG
Today's Pharma Headlines: FDA grants orphan drug status for Motif Bio’s Staphylococcus Aureus lung treatment - Ultragenyx proposes to acquire Dimension Therapeutics - Roche says Venetoclax combination improves PFS in phase III CLL trial - ...